PRECLINICAL DEVELOPMENT

Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact ADME and improve the fate of many of these candidates, improving PK profiles and PD responses.

With specialized capabilities and experience, Catalent offers comprehensive evaluations of compounds from formulation through preclinical in vivo proof-of-concept and can provide you with preclinical formulations to help you move more molecules from discovery to development.